Related Experiment Videos
Fluctuations in T helper subpopulations in relapsing-remitting multiple sclerosis
E Corrigan1, M Hutchinson, C Feighery
1Department of Immunology, St. James' Hospital, Dublin, Ireland.
Acta Neurologica Scandinavica
|May 1, 1990
Summary
Multiple sclerosis (MS) relapse is linked to a shift in CD4+ T-cell subsets. Specifically, resting CD4+ CD45R+ cells decrease while primed CD4+ CD45R- cells increase during active MS.
Area of Science:
- Immunology
- Neuroimmunology
- Cell Biology
Background:
- Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system.
- Previous studies suggest a depletion of immature resting CD4+ T-cells (CD4+ CD45R+) in patients with active MS.
Purpose of the Study:
- To investigate the dynamic changes in CD4+ T-cell subsets (CD4+ CD45R+ and CD4+ CD45R-) during different disease states in multiple sclerosis.
- To determine if these T-cell subset alterations correlate with disease activity and relapse.
Main Methods:
- Flow cytometry was used to quantify CD4+ CD45R+ and CD4+ CD45R- T-cell subsets in 30 MS patients and 17 healthy controls.
- Measurements were taken every 6 weeks over a 6-month period, comparing relapse and remission phases.
- Statistical analysis, including comparison of ratios and disease activity parameters, was performed.
Main Results:
- CD4+ CD45R- cells were significantly increased during MS relapse compared to remission (p < 0.005).
- CD4+ CD45R+ cell levels showed no significant alteration between relapse and remission.
- The ratio of CD4+ CD45R- to CD4+ CD45R+ cells was significantly higher in relapse (p < 0.002).
Conclusions:
- MS relapse is associated with a conversion of resting CD4+ CD45R+ T-cells into primed CD4+ CD45R- T-cells.
- These findings highlight a potential mechanism involving T-cell subset dynamics in MS pathogenesis.
- The observed changes in T-cell subsets may serve as biomarkers for disease activity in MS.